Soleno Therapeutics, Inc. (NASDAQ:SLNO) is one of the 10 Unstoppable Stocks to Buy According to Hedge Funds. On June 23, TD ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” ...

Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the ...

Conference is the first-ever international meeting jointly hosted by the Prader-Willi Syndrome Association | USA, the ...

A high-level overview of Soleno Therapeutics, Inc. (SLNO) stock. View (SLNO) real-time stock price, chart, news, analysis, analyst reviews and more.

Soleno Therapeutics (SLNO) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Opportunity, LLC Vivo, a 10% owner of $SLNO, sold 1,100,000 shares of the company on 03-27-2025 for an estimated $74,580,000. We received data on the trade from a ...

The latest price target for Soleno Therapeutics (NASDAQ:SLNO) was reported by Guggenheim on May 8, 2025. The analyst firm set a price target for $97.00 expecting SLNO to rise to within 12 months ...

Soleno Therapeutics, Inc. (SLNO) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...